First Time Loading...

Amryt Pharma Holdings Ltd
LSE:AMYT

Watchlist Manager
Amryt Pharma Holdings Ltd Logo
Amryt Pharma Holdings Ltd
LSE:AMYT
Watchlist
Price: 143 GBX -11.73%
Updated: May 7, 2024

Amryt Pharma Holdings Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amryt Pharma Holdings Ltd
Cash from Operating Activities Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Amryt Pharma Holdings Ltd
LSE:AMYT
Cash from Operating Activities
$26.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Cash from Operating Activities
£7.7B
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
1%
AstraZeneca PLC
LSE:AZN
Cash from Operating Activities
$9.7B
CAGR 3-Years
14%
CAGR 5-Years
33%
CAGR 10-Years
4%
Indivior PLC
LSE:INDV
Cash from Operating Activities
-$334m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Cash from Operating Activities
$608m
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
6%
Dechra Pharmaceuticals PLC
LSE:DPH
Cash from Operating Activities
£63.6m
CAGR 3-Years
-16%
CAGR 5-Years
0%
CAGR 10-Years
6%

See Also

What is Amryt Pharma Holdings Ltd's Cash from Operating Activities?
Cash from Operating Activities
26.9m USD

Based on the financial report for Dec 31, 2020, Amryt Pharma Holdings Ltd's Cash from Operating Activities amounts to 26.9m USD.